1 / 1

More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over 180

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.<br><br>To order this 250 page report, which features 140 figures and 170 tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html<br>

kevin987
Download Presentation

More than 65 industry players across the world are presently engaged in evaluating the clinical applications of over 180

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related